New pill aims to fight dengue virus faster

NCT ID NCT06006559

Summary

This study is testing if an oral medicine called EYU688 can help people with dengue fever get better faster. It will compare the drug to a placebo (a pill with no medicine) in 108 adults who have had a fever for less than two days. The main goals are to see if EYU688 lowers the amount of virus in the blood and helps fever go away more quickly.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENGUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Novartis Investigative Site

    RECRUITING

    Manaus, Amazonas, 69040-000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Brasília, Federal District, 71635-580, Brazil

  • Novartis Investigative Site

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, 21040-360, Brazil

  • Novartis Investigative Site

    RECRUITING

    Sorocaba, São Paulo, 18040-425, Brazil

  • Novartis Investigative Site

    RECRUITING

    Sao Jose Rio Preto, 15090 000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Barranquilla, Atlántico, 080012, Colombia

  • Novartis Investigative Site

    RECRUITING

    Bucaramanga, Santander Department, 681017, Colombia

  • Novartis Investigative Site

    RECRUITING

    Cali, Valle del Cauca Department, 760032, Colombia

  • Novartis Investigative Site

    RECRUITING

    Belagavi, Karnataka, 590010, India

  • Novartis Investigative Site

    WITHDRAWN

    Mumbai, Maharashtra, 400008, India

  • Novartis Investigative Site

    RECRUITING

    Pune, Maharashtra, 411013, India

  • Novartis Investigative Site

    RECRUITING

    Jaipur, Rajasthan, 302017, India

  • Novartis Investigative Site

    RECRUITING

    Chennai, Tamil Nadu, 600113, India

  • Novartis Investigative Site

    RECRUITING

    Kuantan, Pahang, 25200, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Ipoh, Perak, 30450, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Seberang Jaya, Pulau Pinang, 13700, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Miri, Sarawak, 98000, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Kuala Selangor, 68000, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Singapore, 169608, Singapore

  • Novartis Investigative Site

    RECRUITING

    Singapore, S308433, Singapore

  • Novartis Investigative Site

    RECRUITING

    Haiphong, 180000, Vietnam

  • Novartis Investigative Site

    RECRUITING

    Hanoi, 100000, Vietnam

  • Novartis Investigative Site

    RECRUITING

    Ho Chi Minh City, 700000, Vietnam

Conditions

Explore the condition pages connected to this study.